Twenty implants with sand-blasted, large-grit, acid-etched (SLA) surfaces (ITI Dental System) were followed up for a period of 12 months, during which the following clinical criteria were evaluated: (a) absence of persistent clinical symptoms (pain, strange sensations, or paresthesia) after the placement of implants; (b) absence of recurring peri-implant inflammation or suppuration; (c) absence of increasing mobility, tested with Periotest; and (d) absence of bone loss or radiolucency around the implants. After 12 months of follow-up, all the loaded implants, after 6 weeks of placement, were approved under all the aforementioned criteria. During the analysis of the increasing mobility, tested with Periotest, and grouping these implants according to the site of implantation (mandible or maxilla), it was possible to observe that the implants presented the same increasing mobility.